XML 22 R10.htm IDEA: XBRL DOCUMENT
v3.24.3

Marketable and Other Securities | 9 Months Ended
--- | ---
Sep. 30, 2024
Marketable Securities [Abstract] |
Marketable and Other Securities | Marketable and Other Securities The following table summarizes the fair value of cash equivalents and marketable debt securities, which approximates cost:
| Fair Value Level |  | September 30, 2024 |  | December 31, 2023
Cash and cash equivalents |  |  |  |  |
Cash and time deposits |  |  | $ | 12,296 |  |  | $ | 8,977 |
Available-for-sale debt securities |  |  |  |  |
U.S. government and agencies | 2 |  | 76 |  |  | 211 |
Corporate debt | 2 |  | 5,160 |  |  | 1,439 |
Sovereign debt | 2 |  | 2,665 |  |  | 734 |
Total available-for-sale debt securities – cash equivalents |  |  | 7,901 |  |  | 2,384 |
Money market funds | 1 |  | 3,547 |  |  | 7,491 |
Total cash and cash equivalents |  |  | $ | 23,744 |  |  | $ | 18,853 |
Marketable debt securities |  |  |  |  |
U.S. government and agencies | 2 |  | $ | 3,477 |  |  | $ | 3,495 |
Corporate debt and other | 2 |  | 4,364 |  |  | 3,529 |
Mortgage and asset-backed | 2 |  | 636 |  |  | 589 |
Total available-for-sale debt securities – marketable securities |  |  | $ | 8,477 |  |  | $ | 7,613 |
Restricted cash |  |  |  |  |
Cash and cash equivalents |  |  | $ | 275 |  |  | $ | 277 |
Money market funds | 1 |  | 2,695 |  |  | 2,787 |
Total restricted cash |  |  | $ | 2,971 |  |  | $ | 3,064 |
Available-for-sale debt securities included above with contractual maturities(a) |  |  |  |
Due in one year or less |  |  | $ | 9,824 |  |  |
Due between one and five years |  |  | 5,770 |  |  |
Total available-for-sale debt securities with contractual maturities |  |  | $ | 15,594 |  |  |
__________ (a)Excludes mortgage and asset-backed securities o f $636 million at September 30, 2024 as these securities are not due at a single maturity date. Proceeds from the sale of available-for-sale debt securities sold prior to maturity were $580 million and $454 million in the three months ended September 30, 2024 and 2023 and $1.6 billion and $1.5 billion in the nine months ended September 30, 2024 and 2023. Net unrealized gains on available-for-sale debt securities were $159 million and insignificant in the three months ended September 30, 2024 and 2023 and $160 million and insignificant in the nine months ended September 30, 2024 and 2023. Cumulative unrealized losses o n available-for-sale debt securities were insignificant and $160 million at September 30, 2024 and December 31, 2023. The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheet to the total shown in the condensed consolidated statement of cash flows:
| September 30, 2024
Cash and cash equivalents | $ | 23,744 |
Restricted cash included in Other current assets | 2,495 |
Restricted cash included in Other assets | 476 |
Total | $ | 26,715 |

X
- Definition The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/320/tableOfContent + Details
Name: | us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_MarketableSecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration